Skip to main content
Professional Technical IVT

chronic myeloid leukemia

Also written as: CML — chronic myeloid leukemia

A slowly progressing blood cancer characterized by the presence of the BCR-ABL fusion gene, typically occurring in the chronic phase initially.

Full Definition

Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm characterized by the presence of the BCR-ABL1 fusion gene, most commonly resulting from the Philadelphia chromosome translocation t(9;22). The disease typically presents in a chronic phase with elevated white blood cell counts and splenomegaly. Without treatment, CML progresses through an accelerated phase to blast crisis. The development of tyrosine kinase inhibitors targeting BCR-ABL1 has dramatically improved outcomes, making CML a largely manageable chronic condition when diagnosed in the chronic phase.

Usage

Usage note: Specify 'chronic myeloid' to distinguish from other leukemia types; CML acceptable after first use.

In Context

  • "The patient's chronic myeloid leukemia was well-controlled on imatinib therapy." — follow-up note
  • "Molecular monitoring showed a major molecular response in this patient with chronic myeloid leukemia." — laboratory report

Also known as

CML chronic myelogenous leukemia chronic granulocytic leukemia

Contrasted with

acute myeloid leukemia chronic lymphocytic leukemia

Don't confuse with

chronic lymphocytic leukemia acute myeloid leukemia

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON